Commentary: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused

Front Med (Lausanne). 2021 Jan 11:7:625440. doi: 10.3389/fmed.2020.625440. eCollection 2020.

Authors

Soroush Seifirad¹, Lance Alquran¹

Affiliation

¹ Department of Internal Medicine, Hackensack Meridian Health Mountainside Medical Center, Montclair, NJ, United States.

No abstract available

Keywords: ARDS; COVID-19; Pirfenidone; antifibrotics; fibrosis.

Publication types

Comment